Clinical Trial

Cardiometabolic Risk Factor Management and Adherence to Antihypertensive Therapy in Patients With Severe Obesity Prior to Bariatric Surgery: a Prospective Longitudinal Cohort Study

Completed
View on ClinicalTrials.gov →
Summary
Patients with severe obesity frequently exhibit elevated cardiovascular risk. Contributing factors could be inadequate recognition and subsequent management of cardiovascular risk factors, and non-adherence to cardiovascular therapy. This prospective longitudinal cohort study aims to systematically assess the management of major cardiovascular risk factors and objectively evaluate adherence to antihypertensive therapy in patients with severe obesity undergoing evaluation for bariatric surgery. Using repeated assessments and direct plasma drug detection, the study seeks to characterise adherence patterns over time and identify clinical factors associated with persistent non-adherence.
Trial Details
NCT Number NCT07441304
Lead Sponsor Universität des Saarlandes
Conditions Severe Obesity Scheduled for Bariatric Surgery
Enrollment 80 participants
Start Date 2022-08-04
Primary Completion 2024-11-26 (estimated)
Study Completion 2025-11-21 (estimated)
Updated on ClinicalTrials.gov 2026-02-27